Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab From HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients With Hematologic Malignancies
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2013.11.010
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2014
Authors
Publisher
Elsevier BV